medtronic dexcom

Medtronic launches MiniMed 670G, Dexcom wins FDA nod for Android G5 app – MassDevice

Posted on

Medtronic, Dexcom

Medtronic (NYSE:MDT) and (NSDQ:DXCM) right now announced respective wins for their diabetes care tech, with Medtronic launching its hybrid closed loop MiniMed 670G within the US and Dexcom profitable an FDA nod for a Google (NSDQ:GOOG) Android G5 Cellular software.

Fridley, Minn.-based Medtronic’s MiniMed 670G is designed to routinely monitor and modify blood sugar ranges in patients with diabetes, measuring blood glucose each 5 minutes and routinely administering or withholding insulin.

Other articles you might like;

Leave a Reply

Your email address will not be published. Required fields are marked *